1-(chloromethyl)-5-nitro-1,2-dihydro-3H-benzo[e]indole-8-carbonitrile hydrochloride | 885227-84-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-(chloromethyl)-5-nitro-1,2-dihydro-3H-benzo[e]indole-8-carbonitrile hydrochloride
• CAS: 885227-84-9
• 化学式: C₁₄H₁₀ClN₃O₂*ClH
• 分子量: 324.166
• InChiKey: YALKBJQZCBMOMJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.79
• 重原子数：
  21.0
• 可旋转键数：
  2.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  78.96
• 氢给体数：
  1.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  1-(chloromethyl)-5-nitro-1,2-dihydro-3H-benzo[e]indole-8-carbonitrile hydrochloride 在 硫酸 、 水 作用下， 反应 1.0h， 以48%的产率得到1-(chloromethyl)-5-nitro-1,2-dihydro-3H-benzo[e]indole-8-carboxamide
  参考文献：
  名称：

  WO2006/43839

  摘要：

  公开号：
• 作为产物：
  描述：

  1-(chloromethyl)-5-nitro-1,2-dihydro-3H-benzo[e]indole-8-carbonitrile 在 盐酸 作用下， 以 1,4-二氧六环 为溶剂， 反应 1.0h， 以100%的产率得到1-(chloromethyl)-5-nitro-1,2-dihydro-3H-benzo[e]indole-8-carbonitrile hydrochloride
  参考文献：
  名称：

  WO2006/43839

  摘要：

  公开号：

文献信息

• Hypoxia-Activated Prodrugs: Substituent Effects on the Properties of Nitro <i>seco</i>-1,2,9,9a-Tetrahydrocyclopropa[<i>c</i>]benz[<i>e</i>]indol-4-one (nitroCBI) Prodrugs of DNA Minor Groove Alkylating Agents
  作者：Moana Tercel、Graham J. Atwell、Shangjin Yang、Ralph J. Stevenson、K. Jane Botting、Maruta Boyd、Eileen Smith、Robert F. Anderson、William A. Denny、William R. Wilson、Frederik B. Pruijn

  DOI：10.1021/jm901202b

  日期：2009.11.26

  Nitrochloromethylbenzindolines (nitroCBIs) are a new class of hypoxia-activated prodrugs for antitumor therapy. The recently reported prototypes undergo hypoxia-selective metabolism to form potent DNA minor groove alkylating agents and are selectively toxic to some but not all hypoxic tumor cell lines. Here we report a series of 31 analogues that bear an extra electron-withdrawing substituent that serves to raise the one-electron reduction potential of the nitroCBI. We identify a subset of compounds, those with a basic side chain and sulfonamide or carboxamide substituent, that have consistently high hypoxic selectivity. The best of these, with a 7-sulfonamide substituent, displays hypoxic cytotoxicity ratios of 275 and 330 in Skov3 and HT29 human tumor cell lines, respectively. This compound (28) is efficiently and selectively metabolized to the corresponding aminoCBI, is selectively cytotoxic tinder hypoxia in all 11 cell lines examined, and demonstrates activity against hypoxic tumor cells in a human tumor xenograft in vivo.